These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4650194)

  • 1. Duchenne muscular dystrophy.
    Ossipov AI; Gujral YV; Trufanov VF; Trufanova VP; Ussova JI; Ossipova TP
    Indian Pediatr; 1972 Jul; 9(7):403-5. PubMed ID: 4650194
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigation on healthy individuals from families of patients with Duchenne type muscular dystrophy.
    Hausmanowa-Petrusewicz I; Prot J; Niebrój-Dobosz I; Emeryk B; Wasowicz B; Slucka C; Hetnarska L; Bendarzewska B; Pucek Z
    Pol Med J; 1968; 7(1):228-37. PubMed ID: 5652928
    [No Abstract]   [Full Text] [Related]  

  • 3. [Duchenne muscular dystrophy. Effects of vitamin E administration on urinary luminescence].
    Pizarro M; Lissi E; Reyes J; Holmgren J
    Rev Med Chil; 1998 Oct; 126(10):1165-72. PubMed ID: 10030087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered polyamine excretion in Duchenne muscular dystrophy.
    Russell DH; Stern LZ
    Neurology; 1981 Jan; 31(1):80-3. PubMed ID: 7192830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
    Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
    Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiocirculatory findings in the progressive muscular dystrophy of Duchenne du Boulogne].
    Castellani A; Ippoliti B; Tezzele A
    Folia Cardiol; 1969; 28():11-33. PubMed ID: 5409240
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of urinary creatinine and creatine in progressive muscular dystrophy].
    Sato N; Kanno M; Annaka S
    Iryo; 1968 Dec; 22(12):1372-8. PubMed ID: 5717703
    [No Abstract]   [Full Text] [Related]  

  • 8. Catecholamines and indoleamines in patients with Duchenne muscular dystrophy.
    Mendell JR; Murphy DL; Engel WK; Chase TN; Gordon E
    Arch Neurol; 1972 Dec; 27(6):518-20. PubMed ID: 5083869
    [No Abstract]   [Full Text] [Related]  

  • 9. Duchenne muscular dystrophy, preclinical diagnosis.
    Murdoch JL
    Birth Defects Orig Artic Ser; 1971 Feb; 7(2):110. PubMed ID: 5173117
    [No Abstract]   [Full Text] [Related]  

  • 10. [Significance of electro-vectorcardiographic changes in patients and carriers of Duchenne muscular dystrophy].
    Wu SC; Secchi MB; Obbiassi M; Mancarella S; Vitolo E; Folli G
    Boll Soc Ital Cardiol; 1981; 26(1):29-39. PubMed ID: 7340857
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical studies in progressive muscular dystrophy.
    Prot J
    Pol Med J; 1972; 11(4):1004-12. PubMed ID: 5078704
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical studies on muscular dystrophy. Serum and urine creatine, creatinine and aminoacids.
    el-Nabawy M; Sakr R; el-Hawary MF
    J Egypt Med Assoc; 1968; 51(11):949-63. PubMed ID: 5714513
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nursing process/nursing of patients with muscular dystrophy. A case study and nursing of a patient with Duchenne type muscular dystrophy].
    Watanabe Y; Higashiyama K; Fukuda S
    Kurinikaru Sutadi; 1981 Sep; 2(9):1050-68. PubMed ID: 6915321
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased rates of myofibrillar protein breakdown in muscle-wasting diseases.
    Warnes DM; Tomas FM; Ballard FJ
    Muscle Nerve; 1981; 4(1):62-6. PubMed ID: 7231447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical symptoms in a female carrier of Duchenne muscular dystrophy.
    Zatz M; Levisky RB; Levy JA; Valente BO; Gianotti M; Frota-Pessoa O
    J Genet Hum; 1973 Dec; 21(4):297-305. PubMed ID: 4792239
    [No Abstract]   [Full Text] [Related]  

  • 16. Duchenne muscular dystrophy and idiopathic hyperCKemia in a family causing confusion in genetic counselling.
    Bushby K; Goodship J; Haggerty D; Heald A; Walls T
    Am J Med Genet; 1996 Dec; 66(2):237-8. PubMed ID: 8958338
    [No Abstract]   [Full Text] [Related]  

  • 17. Two families with late onset pseudohypertrophic muscular dystrophy (Becker type).
    Lee WL; Wong HB
    J Singapore Paediatr Soc; 1981; 23(3-4):159-63. PubMed ID: 7052857
    [No Abstract]   [Full Text] [Related]  

  • 18. [Electrocardiographic findings in the Duchenne-type of progressive muscular dystrophy].
    Nakagawa K; Okamoto S; Goto H; Kato T; Yamamoto K
    Iryo; 1968 Dec; 22(12):1425-38. PubMed ID: 5717711
    [No Abstract]   [Full Text] [Related]  

  • 19. Genotype and electroretinal heterogeneity in Duchenne muscular dystrophy.
    Ino-ue M; Honda S; Nishio H; Matsuo M; Nakamura H; Yamamoto M
    Exp Eye Res; 1997 Dec; 65(6):861-4. PubMed ID: 9441711
    [No Abstract]   [Full Text] [Related]  

  • 20. Motor nerve conduction in Duchenne type of muscular dystrophy.
    Jayam AV; Raju TN; Pandya SS; Desai AD
    Neurol India; 1970 Mar; 18(1):8-12. PubMed ID: 5439386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.